An assessment of the impact of Raman based glucose feedback control on CHO cell bioreactor process development
Biotechnology Progress · 2023-09 · 39 (5)
DOI: 10.1002/btpr.3371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Progress, online erschienen am 27.06.2023. Verfasst von Luke Gibbons und 12 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Glucose, Bioreactors. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Irish Research Council for Science, Engineering and Technology.
Abstract (Originalsprache)
Process analytical technology (PAT) tools such as Raman Spectroscopy have become established tools for real time measurement of CHO cell bioreactor process variables and are aligned with the QbD approach to manufacturing. These tools can have a significant impact on process development if adopted early, creating an end‐to‐end PAT/QbD focused process. This study assessed the impact of Raman based feedback control on early and late phase development bioreactors by using a Raman based PLS model and PAT management system to control glucose in two CHO cell line bioreactor processes. The impact was then compared to bioreactor processes which used manual bolus fed methods for glucose feed delivery. Process improvements were observed in terms of overall bioreactor health, product output and product quality. Raman controlled batches for Cell Line 1 showed a reduction in glycation of 43.4% and 57.9%, respectively. Cell Line 2 batches with Raman based feedback control showed an improved growth profile with higher VCD and viability and a resulting 25% increase in overall product titer with an improved glycation profile. The results presented here demonstrate that Raman spectroscopy can be used in both early and late‐stage process development and design for consistent and controlled glucose feed delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapeutics Development, Janssen Sciences Ireland UC, Cork, Ireland.
- Department of Biological Sciences, Munster Technological University, Cork, Ireland.
- BioTherapeutic Development, Janssen Pharmaceutical Companies of Johnson and Johnson, Malvern, Pennsylvania, USA.
ORCID-Profile: Luke Gibbons
Förderung
- Irish Research Council for Science, Engineering and Technology
Zitieren
APA
Gibbons, L., Maslanka, F., Le, N., Magill, A., Singh, P., Mclaughlin, J., Madden, F., Hayes, R., McCarthy, B., Rode, C., O'Mahony, J., Rea, R., & O'Mahony-Hartnett, C. (2023). An assessment of the impact of Raman based glucose feedback control on CHO cell bioreactor process development. Biotechnology Progress, 39(5). https://doi.org/10.1002/btpr.3371
Vancouver
Gibbons L, Maslanka F, Le N, Magill A, Singh P, Mclaughlin J, et al. An assessment of the impact of Raman based glucose feedback control on CHO cell bioreactor process development. Biotechnology Progress. 2023;39(5). doi:10.1002/btpr.3371
BibTeX
@article{Gibbons2023,
author = {Gibbons, Luke and Maslanka, Francis and Le, Nikky and Magill, Al and Singh, Pankaj and Mclaughlin, Joseph and Madden, Fiona and Hayes, Ronan and McCarthy, Barry and Rode, Christopher and O'Mahony, Jim and Rea, Rosemary and O'Mahony-Hartnett, Caitlin},
title = {An assessment of the impact of Raman based glucose feedback control on CHO cell bioreactor process development},
journal = {Biotechnology Progress},
year = {2023},
volume = {39},
number = {5},
doi = {10.1002/btpr.3371}
}
EUVIMED